Moleculin Biotech, Inc. Increase (Decrease) in Due to Related Parties
Moleculin Biotech, Inc. (MBRX) reported Increase (Decrease) in Due to Related Parties of $87.50 thousand for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-21.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueToRelatedParties · last filed 2016-11-21
- 2016-09-30: Increase (Decrease) in Due to Related Parties 9 month $87.50K.
- 2015-09-30: Increase (Decrease) in Due to Related Parties 2 month $19.58K.
| Period end | Increase (Decrease) in Due to Related Parties 2 month | Increase (Decrease) in Due to Related Parties 9 month |
|---|---|---|
| 2016-09-30 | $87.50K 10-Q · filed 2016-11-21 | |
| 2015-09-30 | $19.58K 10-Q · filed 2016-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |